Skip to main content
SpringerLink
Log in

Cytomegalovirus Immune Evasion

  • Chapter
Human Cytomegalovirus

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 325))

Human cytomegalovirus (HCMV) has become a paradigm for viral immune evasion due to its unique multitude of immune-modulatory strategies. HCMV modulates the innate as well as adaptive immune response at every step of its life cycle. It dampens the induction of antiviral interferon-induced genes by several mechanisms. Further striking is the multitude of genes and strategies devoted to modulating and escaping the cellular immune response. Several genes are independently capable of inhibiting antigen presentation to cytolytic T cells by downregulating MHC class I. Recent data revealed an astounding variety of methods in triggering or inhibiting activatory and inhibitory receptors found on NK cells, NKT cells, T cells as well as auxiliary cells of the immune system. The multitude and complexity of these mechanisms is fascinating and continues to reveal novel insights into the host–pathogen interaction and novel cell biological and immunological concepts.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abate DA, Watanabe S, Mocarski ES (2004) Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. J Virol 78:10995–11006.

    Article  PubMed  CAS  Google Scholar 

  • Abenes G, Lee M, Haghjoo E, Tong T, Zhan X, Liu F (2001) Murine cytomegalovirus open reading frame M27 plays an important role in growth and virulence in mice. J Virol 75:1697–1707.

    Article  PubMed  CAS  Google Scholar 

  • Adam SG, Caraux A, Fodil-Cornu N, Loredo-Osti JC, Lesjean-Pottier S, Jaubert J, Bubic I, Jonjic S, Guenet JL, Vidal SM, Colucci F (2006) Cmv4, a new locus linked to the NK cell gene complex, controls innate resistance to cytomegalovirus in wild-derived mice. J Immunol 176:5478–5485.

    PubMed  CAS  Google Scholar 

  • Ahn K, Angulo A, Ghazal P, Peterson PA, Yang Y, Fruh K (1996) Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc Natl Acad Sci U S A 93:10990–10995.

    Article  PubMed  CAS  Google Scholar 

  • Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, Goodbourn S, Randall RE (2004) The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci U S A 101:17264–17269.

    Article  PubMed  CAS  Google Scholar 

  • Antrobus RD, Khan N, Hislop AD, Montamat-Sicotte D, Garner LI, Rickinson AB, Moss PA, Willcox BE (2005) Virus-specific cytotoxic T lymphocytes differentially express cell-surface leukocyte immunoglobulin-like receptor-1, an inhibitory receptor for class I major histocompatibility complex molecules. J Infect Dis 191:1842–1853.

    Article  PubMed  CAS  Google Scholar 

  • Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL (2002) Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296:1323–1326.

    Article  PubMed  CAS  Google Scholar 

  • Arav-Boger R, Willoughby RE, Pass RF, Zong JC, Jang WJ, Alcendor D, Hayward GS (2002) Polymorphisms of the cytomegalovirus (CMV)-encoded tumor necrosis factor-alpha and beta-chemokine receptors in congenital CMV disease. J Infect Dis 186:1057–1064.

    Article  PubMed  CAS  Google Scholar 

  • Arav-Boger R, Battaglia CA, Lazzarotto T, Gabrielli L, Zong JC, Hayward GS, Diener-West M, Landini MP (2006) Cytomegalovirus (CMV)-encoded UL144 (truncated tumor necrosis factor receptor) and outcome of congenital CMV infection. J Infect Dis 194:464–473.

    Article  PubMed  Google Scholar 

  • Arnon TI, Achdout H, Levi O, Markel G, Saleh N, Katz G, Gazit R, Gonen-Gross T, Hanna J, Nahari E, Porgador A, Honigman A, Plachter B, Mevorach D, Wolf DG, Mandelboim O (2005) Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat Immunol 6:515–523.

    Article  PubMed  CAS  Google Scholar 

  • Atalay R, Zimmermann A, Wagner M, Borst E, Benz C, Messerle M, Hengel H (2002) Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J Virol 76:8596–8608.

    Article  PubMed  CAS  Google Scholar 

  • Bale JF Jr, Petheram SJ, Robertson M, Murph JR, Demmler G (2001) Human cytomegalovirus a sequence and UL144 variability in strains from infected children. J Med Virol 65:90–96.

    Article  PubMed  CAS  Google Scholar 

  • Barel MT, Pizzato N, Le Bouteiller P, Wiertz EJ, Lenfant F (2006) Subtle sequence variation among MHC class I locus products greatly influences sensitivity to HCMV US2- and US11-mediated degradation. Int Immunol 18:173–182.

    Article  PubMed  CAS  Google Scholar 

  • Bartee E, McCormack A, Fruh K (2006) Quantitative membrane proteomics reveals new cellular targets of viral immune modulators. PLoS Pathog 2:e107.

    Article  PubMed  CAS  Google Scholar 

  • Basta S, Bennink JR (2003) A survival game of hide and seek: cytomegaloviruses and MHC class I antigen presentation pathways. Viral Immunol 16:231–242.

    Article  PubMed  CAS  Google Scholar 

  • Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T (1999) Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285:727–729.

    Article  PubMed  CAS  Google Scholar 

  • Beck S, Barrell BG (1988) Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature 331:269–272.

    Article  PubMed  CAS  Google Scholar 

  • Benedict CA, Butrovich KD, Lurain NS, Corbeil J, Rooney I, Schneider P, Tschopp J, Ware CF (1999) Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. J Immunol 162:6967–6970.

    PubMed  CAS  Google Scholar 

  • Berg L, Riise GC, Cosman D, Bergstrom T, Olofsson S, Karre K, Carbone E (2003) LIR-1 expression on lymphocytes, and cytomegalovirus disease in lung-transplant recipients. Lancet 361:1099–1101.

    Article  PubMed  CAS  Google Scholar 

  • Biron CA, Byron KS, Sullivan JL (1989) Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 320:1731–1735.

    PubMed  CAS  Google Scholar 

  • Booth TW, Scalzo AA, Carrello C, Lyons PA, Farrell HE, Singleton GR, Shellam GR (1993) Molecular and biological characterization of new strains of murine cytomegalovirus isolated from wild mice. Arch Virol 132:209–220.

    Article  PubMed  CAS  Google Scholar 

  • Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ (2001) Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 344:1366–1371.

    Article  PubMed  CAS  Google Scholar 

  • Borges L, Hsu ML, Fanger N, Kubin M, Cosman D (1997) A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J Immunol 159:5192–5196.

    PubMed  CAS  Google Scholar 

  • Borges L, Cosman D (2000) LIRs/ILTs/MIRs, inhibitory and stimulatory Ig-superfamily receptors expressed in myeloid and lymphoid cells. Cytokine Growth Factor Rev 11:209–217.

    Article  PubMed  CAS  Google Scholar 

  • Bottino C, Castriconi R, Pende D, Rivera P, Nanni M, Carnemolla B, Cantoni C, Grassi J, Marcenaro S, Reymond N, Vitale M, Moretta L, Lopez M, Moretta A (2003) Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med 198: 557–567.

    Article  PubMed  CAS  Google Scholar 

  • Braud V, Jones EY, McMichael A (1997) The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur J Immunol 27:1164–1169.

    Article  PubMed  CAS  Google Scholar 

  • Bresnahan WA, Shenk TE (2000) UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cells. Proc Natl Acad Sci USA 97:14506–14511.

    Article  PubMed  CAS  Google Scholar 

  • Brown MG, Dokun AO, Heusel JW, Smith HR, Beckman DL, Blattenberger EA, Dubbelde CE, Stone LR, Scalzo AA, Yokoyama WM (2001) Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292:934–937.

    Article  PubMed  CAS  Google Scholar 

  • Browne EP, Shenk T (2003) Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells. Proc Natl Acad Sci USA 100:11439–11444.

    Article  PubMed  CAS  Google Scholar 

  • Browne EP, Wing B, Coleman D, Shenk T (2001) Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs. J Virol 75:12319–12330.

    Article  PubMed  CAS  Google Scholar 

  • Browne H, Smith G, Beck S, Minson T (1990) A complex between the MHC class I homologue encoded by human cytomegalovirus and beta 2 microglobulin. Nature 347:770–772.

    Article  PubMed  CAS  Google Scholar 

  • Bubic I, Wagner M, Krmpotic A, Saulig T, Kim S, Yokoyama WM, Jonjic S, Koszinowski UH (2004) Gain of virulence caused by loss of a gene in murine cytomegalovirus. J Virol 78:7536–7544.

    Article  PubMed  CAS  Google Scholar 

  • Cantrell SR, Bresnahan WA (2005) Interaction between the human cytomegalovirus UL82 gene product (pp71) and hDaxx regulates immediate-early gene expression and viral replication. J Virol 79:7792–7802.

    Article  PubMed  CAS  Google Scholar 

  • Carayannopoulos LN, Naidenko OV, Fremont DH, Yokoyama WM (2002) Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J Immunol 169:4079–4083.

    PubMed  CAS  Google Scholar 

  • Carlyle JR, Jamieson AM, Gasser S, Clingan CS, Arase H, Raulet DH (2004) Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors. Proc Natl Acad Sci USA 101:3527–3532.

    Article  PubMed  CAS  Google Scholar 

  • Cerboni C, Mousavi-Jazi M, Wakiguchi H, Carbone E, Karre K, Soderstrom K (2001) Synergistic effect of IFN-gamma and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity. Eur J Immunol 31:2926–2935.

    Article  PubMed  CAS  Google Scholar 

  • Cerwenka A, Bakker AB, McClanahan T, Wagner J, Wu J, Phillips JH, Lanier LL (2000) Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12:721–727.

    Article  PubMed  CAS  Google Scholar 

  • Chalupny NJ, Rein-Weston A, Dosch S, Cosman D (2006) Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142. Biochem Biophys Res Commun 346:175–181.

    Article  PubMed  CAS  Google Scholar 

  • Chapman TL, Bjorkman PJ (1998) Characterization of a murine cytomegalovirus class I major histocompatibility complex (MHC) homolog: comparison to MHC molecules and to the human cytomegalovirus MHC homolog. J Virol 72:460–466.

    PubMed  CAS  Google Scholar 

  • Chapman TL, Heikeman AP, Bjorkman PJ (1999) The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 11:603–613.

    Article  PubMed  CAS  Google Scholar 

  • Cheung TC, Humphreys IR, Potter KG, Norris PS, Shumway HM, Tran BR, Patterson G, Jean-Jacques R, Yoon M, Spear PG, Murphy KM, Lurain NS, Benedict CA, Ware CF (2005) Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway. Proc Natl Acad Sci USA 102:13218–13223.

    Article  PubMed  CAS  Google Scholar 

  • Child SJ, Hakki M, De Niro KL, Geballe AP (2004) Evasion of cellular antiviral responses by human cytomegalovirus TRS1 and IRS1. J Virol 78:197–205.

    Article  PubMed  CAS  Google Scholar 

  • Child SJ, Jarrahian S, Harper VM, Geballe AP (2002) Complementation of vaccinia virus lacking the double-stranded RNA-binding protein gene E3L by human cytomegalovirus. J Virol 76:4912–4918.

    Article  PubMed  CAS  Google Scholar 

  • Chin KC, Cresswell P (2001) Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc Natl Acad Sci USA 98:15125–15130.

    Article  PubMed  CAS  Google Scholar 

  • Colonna M (1998) Immunology. Unmasking the killer’s accomplice. Nature 391:642–643.

    Article  PubMed  CAS  Google Scholar 

  • Cosman D, Fanger N, Borges L, Kubin M, Chin W, Peterson L, Hsu ML (1997) A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7:273–282.

    Article  PubMed  CAS  Google Scholar 

  • Cosman D, Mullberg J, Sutherland CL, Chin W, Armitage R, Fanslow W, Kubin M, Chalupny NJ (2001) ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14:123–133.

    Article  PubMed  CAS  Google Scholar 

  • Cresswell P, Ackerman AL, Giodini A, Peaper DR, Wearsch PA (2005) Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol Rev 207:145–157.

    Article  PubMed  CAS  Google Scholar 

  • Crnkovic-Mertens I, Messerle M, Milotic I, Szepan U, Kucic N, Krmpotic A, Jonjic S, Koszinowski UH (1998) Virus attenuation after deletion of the cytomegalovirus Fc receptor gene is not due to antibody control. J Virol 72:1377–1382.

    PubMed  CAS  Google Scholar 

  • Croft M (2003) Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat Rev Immunol 3:609–620.

    Article  PubMed  CAS  Google Scholar 

  • Cull VS, Bartlett EJ, James CM (2002) Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis. Immunology 106:428–437.

    Article  PubMed  CAS  Google Scholar 

  • Daniels KA, Devora G, Lai WC, O’Donnell CL, Bennett M, Welsh RM (2001) Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J Exp Med 194:29–44.

    Article  PubMed  CAS  Google Scholar 

  • Davison AJ, Dolan A, Akter P, Addison C, Dargan DJ, Alcendor DJ, McGeoch DJ, Hayward GS (2003) The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome. J Gen Virol 84:17–28.

    Article  PubMed  CAS  Google Scholar 

  • DeFilippis VR, Früh KJ (2005) Rhesus cytomegalovirus particles prevent activation of interferon regulatory factor 3. J Virol 79:6419–6431.

    Article  PubMed  CAS  Google Scholar 

  • DeFilippis VR, Robinson B, Keck TM, Hansen SG, Nelson JA, Früh K (2006) Interferon regulatory factor 3 is necessary for induction of antiviral genes during human cytomegalovirus infection. J Virol 80:1032–1037.

    Article  PubMed  CAS  Google Scholar 

  • Diefenbach A, Raulet DH (2003) Innate immune recognition by stimulatory immunoreceptors. Curr Opin Immunol 15:37–44.

    Article  PubMed  CAS  Google Scholar 

  • Diefenbach A, Hsia JK, Hsiung MY, Raulet DH (2003) A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. Eur J Immunol 33:381–391.

    Article  PubMed  CAS  Google Scholar 

  • Dighe A, Rodriguez M, Sabastian P, Xie X, McVoy M, Brown MG (2005) Requisite H2k role in NK cell-mediated resistance in acute murine cytomegalovirus-infected MA/My mice. J Immunol 175:6820–6828.

    PubMed  CAS  Google Scholar 

  • Dimasi N, Biassoni R (2005) Structural and functional aspects of the Ly49 natural killer cell receptors. Immunol Cell Biol 83:1–8.

    Article  PubMed  CAS  Google Scholar 

  • Dunn C, Chalupny NJ, Sutherland CL, Dosch S, Sivakumar PV, Johnson DC, Cosman D (2003) Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J Exp Med 197:1427–1439.

    Article  PubMed  CAS  Google Scholar 

  • Fahnestock ML, Johnson JL, Feldman RM, Neveu JM, Lane WS, Bjorkman PJ (1995) The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. Immunity 3:583–590.

    Article  PubMed  CAS  Google Scholar 

  • Falk CS, Mach M, Schendel DJ, Weiss EH, Hilgert I, Hahn G (2002) NK cell activity during human cytomegalovirus infection is dominated by US2–11-mediated HLA class I down-regulation. J Immunol 169:3257–3266.

    PubMed  CAS  Google Scholar 

  • Farrell HE, Vally H, Lynch DM, Fleming P, Shellam GR, Scalzo AA, Davis-Poynter NJ (1997) Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature 386:510–514.

    Article  PubMed  CAS  Google Scholar 

  • Furman MH, Dey N, Tortorella D, Ploegh HL (2002a) The human cytomegalovirus US10 gene product delays trafficking of major histocompatibility complex class I molecules. J Virol 76:11753–11756.

    Article  PubMed  CAS  Google Scholar 

  • Furman MH, Ploegh HL, Tortorella D (2002b) Membrane-specific, host-derived factors are required for US2- and US11-mediated degradation of major histocompatibility complex class I molecules. J Biol Chem 277:3258–3267.

    Article  PubMed  CAS  Google Scholar 

  • Gewurz BE, Gaudet R, Tortorella D, Wang EW, Ploegh HL, Wiley DC (2001) Antigen presentation subverted: structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2. Proc Natl Acad Sci USA 98:6794–6799.

    Article  PubMed  CAS  Google Scholar 

  • Gitlin L, Barchet W, Gilfillan S, Cella M, Beutler B, Flavell RA, Diamond MS, Colonna M (2006) Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci USA 103:8459–8464.

    Article  PubMed  CAS  Google Scholar 

  • Gold MC, Munks MW, Wagner M, Koszinowski UH, Hill AB, Fling SP (2002) The murine cytomegalovirus immunomodulatory gene m152 prevents recognition of infected cells by M45-specific CTL but does not alter the immunodominance of the M45-specific CD8 T cell response in vivo. J Immunol 169:359–365.

    PubMed  CAS  Google Scholar 

  • Gold MC, Munks MW, Wagner M, McMahon CW, Kelly A, Kavanagh DG, Slifka MK, Koszinowski UH, Raulet DH, Hill AB (2004) Murine cytomegalovirus interference with antigen presentation has little effect on the size or the effector memory phenotype of the CD8 T cell response. J Immunol 172:6944–6953.

    PubMed  CAS  Google Scholar 

  • Grandea AG 3rd, Van Kaer L (2001) Tapasin: an ER chaperone that controls MHC class I assembly with peptide. Trends Immunol 22:194–199.

    Article  PubMed  CAS  Google Scholar 

  • Gribaudo G, Ravaglia S, Caliendo A, Cavallo R, Gariglio M, Martinotti MG, Landolfo S (1993) Interferons inhibit onset of murine cytomegalovirus immediate-early gene transcription. Virology 197:303–311.

    Article  PubMed  CAS  Google Scholar 

  • Griffin C, Wang EC, McSharry BP, Rickards C, Browne H, Wilkinson GW, Tomasec P (2005) Characterization of a highly glycosylated form of the human cytomegalovirus HLA class I homologue gpUL18. J Gen Virol 86:2999–3008.

    Article  PubMed  CAS  Google Scholar 

  • Guma M, Budt M, Saez A, Brckalo T, Hengel H, Angulo A, Lopez-Botet M (2006) Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 107:3624–3631.

    Article  PubMed  CAS  Google Scholar 

  • Hansen SG, Strelow LI, Franchi DC, Anders DG, Wong SW (2003) Complete sequence and genomic analysis of rhesus cytomegalovirus. J Virol 77:6620–6636.

    Article  PubMed  CAS  Google Scholar 

  • Hao L, Klein J, Nei M (2006) Heterogeneous but conserved natural killer receptor gene complexes in four major orders of mammals. Proc Natl Acad Sci USA 103:3192–3197.

    Article  PubMed  CAS  Google Scholar 

  • Hasan M, Krmpotic A, Ruzsics Z, Bubic I, Lenac T, Halenius A, Loewendorf A, Messerle M, Hengel H, Jonjic S, Koszinowski UH (2005) Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. J Virol 79:2920–2930.

    Article  PubMed  CAS  Google Scholar 

  • Hassink GC, Barel MT, Van Voorden SB, Kikkert M, Wiertz EJ (2006) Ubiquitination of MHC class I heavy chains is essential for dislocation by human cytomegalovirus-encoded US2 but not US11. J Biol Chem 281:30063–30071.

    Article  PubMed  CAS  Google Scholar 

  • He R, Ruan Q, Xia C, Liu LQ, Lu SM, Lu Y, Qi Y, Ma YP, Liu Q, Ji YH (2004) Sequence variability of human cytomegalovirus UL144 open reading frame in low-passage clinical isolates. Chin Med Sci J 19:293–297.

    PubMed  CAS  Google Scholar 

  • Hegde NR, Chevalier MS, Wisner TW, Denton MC, Shire K, Frappier L, Johnson DC (2006) The role of BiP in endoplasmic reticulum-associated degradation of major histocompatibility complex class I heavy chain induced by cytomegalovirus proteins. J Biol Chem 281:20910–20919.

    Article  PubMed  CAS  Google Scholar 

  • Hewitt EW, Gupta SS, Lehner PJ (2001) The human cytomegalovirus gene product US6 inhibits ATP binding by TAP. EMBO J 20:387–396.

    Article  PubMed  CAS  Google Scholar 

  • Hiscott J, Grandvaux N, Sharma S, Tenoever BR, Servant MJ, Lin R (2003) Convergence of the NF-kappaB and interferon signaling pathways in the regulation of antiviral defense and apoptosis. Ann NY Acad Sci 1010:237–248.

    Article  PubMed  CAS  Google Scholar 

  • Holowaty MN, Zeghouf M, Wu H, Tellam J, Athanasopoulos V, Greenblatt J, Frappier L (2003) Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7. J Biol Chem 278:29987–29994.

    Article  PubMed  CAS  Google Scholar 

  • Holtappels R, Podlech J, Pahl-Seibert MF, Julch M, Thomas D, Simon CO, Wagner M, Reddehase MJ (2004) Cytomegalovirus misleads its host by priming of CD8 T cells specific for an epitope not presented in infected tissues. J Exp Med 199:131–136.

    Article  PubMed  CAS  Google Scholar 

  • Huard B, Fruh K (2000) A role for MHC class I down-regulation in NK cell lysis of herpes virus-infected cells. Eur J Immunol 30:509–515.

    Article  PubMed  CAS  Google Scholar 

  • Huber MT, Tomazin R, Wisner T, Boname J, Johnson DC (2002) Human cytomegalovirus US7, US8, US9, and US10 are cytoplasmic glycoproteins, not found at cell surfaces, and US9 does not mediate cell-to-cell spread. J Virol 76:5748–5758.

    Article  PubMed  CAS  Google Scholar 

  • Iizuka K, Naidenko OV, Plougastel BF, Fremont DH, Yokoyama WM (2003) Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat Immunol 4:801–807.

    Article  PubMed  CAS  Google Scholar 

  • Johnson DC, Hegde NR (2002) Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus. Curr Top Microbiol Immunol 269:101–115.

    PubMed  CAS  Google Scholar 

  • Jones TR, Wiertz EJ, Sun L, Fish KN, Nelson JA, Ploegh HL (1996) Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci U S A 93:11327–11333.

    Article  PubMed  CAS  Google Scholar 

  • Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K, Tsujimura T, Takeda K, Fujita T, Takeuchi O, Akira S (2005) Cell type-specific involvement of RIG-I in antiviral response. Immunity 23:19–28.

    Article  PubMed  CAS  Google Scholar 

  • Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101–105.

    Article  PubMed  CAS  Google Scholar 

  • Kavanagh DG, Koszinowski UH, Hill AB (2001) The murine cytomegalovirus immune evasion protein m4/gp34 forms biochemically distinct complexes with class I MHC at the cell surface and in a pre-Golgi compartment. J Immunol 167:3894–3902.

    PubMed  CAS  Google Scholar 

  • Kawai T, Akira S (2006) TLR signaling. Cell Death Differ 13:816–825.

    Article  PubMed  CAS  Google Scholar 

  • Kielczewska A, Kim HS, Lanier LL, Dimasi N, Vidal SM (2007) Critical residues at the Ly49 natural killer receptor’s homodimer interface determine functional recognition of m157, a mouse cytomegalovirus MHC class I-like protein. J Immunol 178:369–377.

    PubMed  CAS  Google Scholar 

  • Kleijnen MF, Huppa JB, Lucin P, Mukherjee S, Farrell H, Campbell AE, Koszinowski UH, Hill AB, Ploegh HL (1997) A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. EMBO J 16:685–694.

    Article  PubMed  CAS  Google Scholar 

  • Krmpotic A, Messerle M, Crnkovic-Mertens I, Polic B, Jonjic S, Koszinowski UH (1999) The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against T cell control in vivo. J Exp Med 190:1285–1296.

    Article  PubMed  CAS  Google Scholar 

  • Krmpotic A, Busch DH, Bubic I, Gebhardt F, Hengel H, Hasan M, Scalzo AA, Koszinowski UH, Jonjic S (2002) MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat Immunol 3:529–535.

    Article  PubMed  CAS  Google Scholar 

  • Krmpotic A, Hasan M, Loewendorf A, Saulig T, Halenius A, Lenac T, Polic B, Bubic I, Kriegeskorte A, Pernjak-Pugel E, Messerle M, Hengel H, Busch DH, Koszinowski UH, Jonjic S (2005) NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J Exp Med 201:211–220.

    Article  PubMed  CAS  Google Scholar 

  • Kubin M, Cassiano L, Chalupny J, Chin W, Cosman D, Fanslow W, Mullberg J, Rousseau AM, Ulrich D, Armitage R (2001) ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells. Eur J Immunol 31:1428–1437.

    Article  PubMed  CAS  Google Scholar 

  • Kubota A, Kubota S, Farrell HE, Davis-Poynter N, Takei F (1999) Inhibition of NK cells by murine CMV-encoded class I MHC homologue m144. Cell Immunol 191:145–151.

    Article  PubMed  CAS  Google Scholar 

  • Lanier LL (1998) NK cell receptors. Annu Rev Immunol 16:359–393.

    Article  PubMed  CAS  Google Scholar 

  • Lee N, Llano M, Carretero M, Ishitani A, Navarro F, Lopez-Botet M, Geraghty DE (1998) HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci U S A 95:5199–5204.

    Article  PubMed  CAS  Google Scholar 

  • Lee SH, Girard S, Macina D, Busa M, Zafer A, Belouchi A, Gros P, Vidal SM (2001) Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat Genet 28:42–45.

    Article  PubMed  CAS  Google Scholar 

  • Lenac T, Budt M, Arapovic J, Hasan M, Zimmermann A, Simic H, Krmpotic A, Messerle M, Ruzsics Z, Koszinowski UH, Hengel H, Jonjic S (2006) The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. J Exp Med 203:1843–1850.

    Article  PubMed  CAS  Google Scholar 

  • Leong CC, Chapman TL, Bjorkman PJ, Formankova D, Mocarski ES, Phillips JH, Lanier LL (1998) Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J Exp Med 187:1681–1687.

    Article  PubMed  CAS  Google Scholar 

  • Lilley BN, Ploegh HL (2004) A membrane protein required for dislocation of misfolded proteins from the ER. Nature 429:834–840.

    Article  PubMed  CAS  Google Scholar 

  • Lilley BN, Tortorella D, Ploegh HL (2003) Dislocation of a type I membrane protein requires interactions between membrane-spanning segments within the lipid bilayer. Mol Biol Cell 14:3690–3698.

    Article  PubMed  CAS  Google Scholar 

  • Lockridge KM, Zhou SS, Kravitz RH, Johnson JL, Sawai ET, Blewett EL, Barry PA (2000) Primate cytomegaloviruses encode and express an IL-10-like protein. Virology 268:272–280.

    Article  PubMed  CAS  Google Scholar 

  • Locksley RM, Killeen N, Lenardo MJ (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104:487–501.

    Article  PubMed  CAS  Google Scholar 

  • Lodoen M, Ogasawara K, Hamerman JA, Arase H, Houchins JP, Mocarski ES, Lanier LL (2003) NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J Exp Med 197:1245–1253.

    Article  PubMed  CAS  Google Scholar 

  • Lodoen MB, Abenes G, Umamoto S, Houchins JP, Liu F, Lanier LL (2004) The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions. J Exp Med 200:1075–1081.

    Article  PubMed  CAS  Google Scholar 

  • Loewendorf A, Kruger C, Borst EM, Wagner M, Just U, Messerle M (2004) Identification of a mouse cytomegalovirus gene selectively targeting CD86 expression on antigen-presenting cells. J Virol 78:13062–13071.

    Article  PubMed  CAS  Google Scholar 

  • Loureiro J, Lilley BN, Spooner E, Noriega V, Tortorella D, Ploegh HL (2006) Signal peptide peptidase is required for dislocation from the endoplasmic reticulum. Nature 441:894–897.

    Article  PubMed  CAS  Google Scholar 

  • Lu X, Pinto AK, Kelly AM, Cho KS, Hill AB (2006) Murine cytomegalovirus interference with antigen presentation contributes to the inability of CD8 T cells to control virus in the salivary gland. J Virol 80:4200–4202.

    Article  PubMed  CAS  Google Scholar 

  • Lurain NS, Kapell KS, Huang DD, Short JA, Paintsil J, Winkfield E, Benedict CA, Ware CF, Bremer JW (1999) Human cytomegalovirus UL144 open reading frame: sequence hypervariability in low-passage clinical isolates. J Virol 73:10040–10050.

    PubMed  CAS  Google Scholar 

  • Ma YP, Ruan Q, He R, Qi Y, Sun ZR, Ji YH, Huang YJ, Liu Q, Chen SR, Wang JD (2006) Sequence variability of the human cytomegalovirus UL141 open reading frame in clinical strains. Arch Virol 151:827–835.

    Article  PubMed  CAS  Google Scholar 

  • Malarkannan S, Shih PP, Eden PA, Horng T, Zuberi AR, Christianson G, Roopenian D, Shastri N (1998) The molecular and functional characterization of a dominant minor H antigen, H60. J Immunol 161:3501–3509.

    PubMed  CAS  Google Scholar 

  • Mao ZQ, He R, Sun M, Qi Y, Huang YJ, Ruan Q (2007) The relationship between polymorphisms of HCMV UL144 ORF and clinical manifestations in 73 strains with congenital and/or perinatal HCMV infection. Arch Virol 152:115–124.

    Article  PubMed  CAS  Google Scholar 

  • Martin MU, Wesche H (2002) Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim Biophys Acta 1592:265–280.

    Article  PubMed  CAS  Google Scholar 

  • Mazzarino P, Pietra G, Vacca P, Falco M, Colau D, Coulie P, Moretta L, Mingari MC (2005) Identification of effector-memory CMV-specific T lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion. Eur J Immunol 35:3240–3247.

    Article  PubMed  CAS  Google Scholar 

  • Mesci A, Ljutic B, Makrigiannis AP, Carlyle JR (2006) NKR-P1 biology: from prototype to missing self. Immunol Res 35:13–26.

    Article  PubMed  CAS  Google Scholar 

  • Miller DM, Zhang Y, Rahill BM, Waldman WJ, Sedmak DD (1999) Human cytomegalovirus inhibits IFN-alpha-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-alpha signal transduction. J Immunol 162:6107–6113.

    PubMed  CAS  Google Scholar 

  • Mintern JD, Klemm EJ, Wagner M, Paquet ME, Napier MD, Kim YM, Koszinowski UH, Ploegh HL (2006) Viral interference with B7–1 costimulation: a new role for murine cytomegalovirus fc receptor-1. J Immunol 177:8422–8431.

    PubMed  CAS  Google Scholar 

  • Mocarski ES Jr (2004) Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system. Cell Microbiol 6:707–717.

    Article  PubMed  CAS  Google Scholar 

  • Moretta L, Romagnani C, Pietra G, Moretta A, Mingari MC (2003) NK-CTLs, a novel HLA-E-restricted T-cell subset. Trends Immunol 24:136–143.

    Article  PubMed  CAS  Google Scholar 

  • Munks MW, Pinto AK, Doom CM, Hill AB (2007) Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection. J Immunol 178:7235–7241.

    PubMed  CAS  Google Scholar 

  • Murayama T, Takegoshi M, Tanuma J, Eizuru Y (2005) Analysis of human cytomegalovirus UL144 variability in low-passage clinical isolates in Japan. Intervirology 48:201–206.

    Article  PubMed  CAS  Google Scholar 

  • Natarajan K, Hicks A, Mans J, Robinson H, Guan R, Mariuzza RA, Margulies DH (2006) Crystal structure of the murine cytomegalovirus MHC-I homolog m144. J Mol Biol 358:157–171.

    Article  PubMed  CAS  Google Scholar 

  • Northfield J, Lucas M, Jones H, Young NT, Klenerman P (2005) Does memory improve with age? CD85j (ILT-2/LIR-1) expression on CD8 T cells correlates with ‘memory inflation’ in human cytomegalovirus infection. Immunol Cell Biol 83:182–188.

    Article  PubMed  CAS  Google Scholar 

  • Odeberg J, Cerboni C, Browne H, Karre K, Moller E, Carbone E, Soderberg-Naucler C (2002) Human cytomegalovirus (HCMV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis independent of the downregulation of classical HLA class I molecules or expression of the HCMV class I homologue, UL18. Scand J Immunol 55:149–161.

    Article  PubMed  CAS  Google Scholar 

  • Odeberg J, Plachter B, Branden L, Soderberg-Naucler C (2003) Human cytomegalovirus protein pp65 mediates accumulation of HLA-DR in lysosomes and destruction of the HLA-DR alpha-chain. Blood 101:4870–4877.

    Article  PubMed  CAS  Google Scholar 

  • Oliveira SA, Park SH, Lee P, Bendelac A, Shenk TE (2002) Murine cytomegalovirus m02 gene family protects against natural killer cell-mediated immune surveillance. J Virol 76:885–894.

    Article  PubMed  CAS  Google Scholar 

  • Pande NT, Powers C, Ahn K, Fruh K (2005) Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11. J Virol 79:5786–5798.

    Article  PubMed  CAS  Google Scholar 

  • Park B, Oh H, Lee S, Song Y, Shin J, Sung YC, Hwang SY, Ahn K (2002) The MHC class I homolog of human cytomegalovirus is resistant to down-regulation mediated by the unique short region protein (US) 2, US3, US6, and US11 gene products. J Immunol 168:3464–3469.

    PubMed  CAS  Google Scholar 

  • Park B, Kim Y, Shin J, Lee S, Cho K, Fruh K, Ahn K (2004) Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. Immunity 20:71–85.

    Article  PubMed  CAS  Google Scholar 

  • Park B, Lee S, Kim E, Cho K, Riddell SR, Cho S, Ahn K (2006) Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing. Cell 127:369–382.

    Article  PubMed  CAS  Google Scholar 

  • Paulus C, Krauss S, Nevels M (2006) A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling. Proc Natl Acad Sci U S A 103:3840–3845.

    Article  PubMed  CAS  Google Scholar 

  • Picone O, Costa JM, Chaix ML, Ville Y, Rouzioux C, Leruez-Ville M (2005) Human cytomegalovirus UL144 gene polymorphisms in congenital infections. J Clin Microbiol 43:25–29.

    Article  PubMed  CAS  Google Scholar 

  • Pietra G, Romagnani C, Falco M, Vitale M, Castriconi R, Pende D, Millo E, Anfossi S, Biassoni R, Moretta L, Mingari MC (2001) The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition. Eur J Immunol 31:3687–3693.

    Article  PubMed  CAS  Google Scholar 

  • Pietra G, Romagnani C, Mazzarino P, Falco M, Millo E, Moretta A, Moretta L, Mingari MC (2003) HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes. Proc Natl Acad Sci U S A 100:10896–10901.

    Article  PubMed  CAS  Google Scholar 

  • Pinto AK, Hill AB (2005) Viral interference with antigen presentation to CD8+ T cells: lessons from cytomegalovirus. Viral Immunol 18:434–444.

    Article  PubMed  CAS  Google Scholar 

  • Poole E, King CA, Sinclair JH, Alcami A (2006) The UL144 gene product of human cytomegalovirus activates NFkappaB via a TRAF6-dependent mechanism. EMBO J 25:4390–4399.

    Article  PubMed  CAS  Google Scholar 

  • Prod’homme V, Griffin C, Aicheler RJ, Wang EC, McSharry BP, Rickards CR, Stanton RJ, Borysiewicz LK, Lopez-Botet M, Wilkinson GW, Tomasec P (2007) The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1-NK cells. J Immunol 178:4473–4481.

    PubMed  Google Scholar 

  • Purcell AW, Gorman JJ, Garcia-Peydro M, Paradela A, Burrows SR, Talbo GH, Laham N, Peh CA, Reynolds EC, Lopez De Castro JA, McCluskey J (2001) Quantitative and qualitative influences of tapasin on the class I peptide repertoire. J Immunol 166:1016–1027.

    PubMed  CAS  Google Scholar 

  • Rawlinson WD, Farrell HE, Barrell BG (1996) Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol 70:8833–8849.

    PubMed  CAS  Google Scholar 

  • Reddehase MJ (2002) Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance. Nat Rev Immunol 2:831–844.

    Article  PubMed  CAS  Google Scholar 

  • Reddehase MJ, Simon CO, Podlech J, Holtappels R (2004) Stalemating a clever opportunist: lessons from murine cytomegalovirus. Hum Immunol 65:446–455.

    Article  PubMed  CAS  Google Scholar 

  • Reusch U, Muranyi W, Lucin P, Burgert HG, Hengel H, Koszinowski UH (1999) A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J 18:1081–1091.

    Article  PubMed  CAS  Google Scholar 

  • Reyburn HT, Mandelboim O, Vales-Gomez M, Davis DM, Pazmany L, Strominger JL (1997) The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386:514–517.

    Article  PubMed  CAS  Google Scholar 

  • Rivailler P, Kaur A, Johnson RP, Wang F (2006) Genomic sequence of rhesus cytomegalovirus 180.92: insights into the coding potential of rhesus cytomegalovirus. J Virol 80:4179–4182.

    Article  PubMed  CAS  Google Scholar 

  • Rizvanov AA, van Geelen AG, Morzunov S, Otteson EW, Bohlman C, Pari GS, St Jeor SC (2003) Generation of a recombinant cytomegalovirus for expression of a hantavirus glycoprotein. J Virol 77:12203–12210.

    Article  PubMed  CAS  Google Scholar 

  • Robertson MJ, Cochran KJ, Cameron C, Le JM, Tantravahi R, Ritz J (1996) Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp Hematol 24:406–415.

    PubMed  CAS  Google Scholar 

  • Rodriguez M, Sabastian P, Clark P, Brown MG (2004) Cmv1-independent antiviral role of NK cells revealed in murine cytomegalovirus-infected New Zealand White mice. J Immunol 173:6312–6318.

    PubMed  CAS  Google Scholar 

  • Rolle A, Mousavi-Jazi M, Eriksson M, Odeberg J, Soderberg-Naucler C, Cosman D, Karre K, Cerboni C (2003) Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP) 1 and ULBP2 is counteracted by the viral UL16 protein. J Immunol 171:902–908.

    PubMed  Google Scholar 

  • Romagnani C, Pietra G, Falco M, Millo E, Mazzarino P, Biassoni R, Moretta A, Moretta L, Mingari MC (2002) Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells. Proc Natl Acad Sci U S A 99:11328–11333.

    Article  PubMed  CAS  Google Scholar 

  • Romagnani C, Pietra G, Falco M, Mazzarino P, Moretta L, Mingari MC (2004) HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes. Hum Immunol 65:437–445.

    Article  PubMed  CAS  Google Scholar 

  • Ruger B, Klages S, Walla B, Albrecht J, Fleckenstein B, Tomlinson P, Barrell B (1987) Primary structure and transcription of the genes coding for the two virion phosphoproteins pp65 and pp71 of human cytomegalovirus. J Virol 61:446–453.

    PubMed  CAS  Google Scholar 

  • Sainz B Jr, Lamarca HL, Garry RF, Morris CA (2005) Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma. Virol J 2:14.

    Article  PubMed  CAS  Google Scholar 

  • Salazar-Mather TP, Lewis CA, Biron CA (2002) Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1alpha delivery to the liver. J Clin Invest 110:321–330.

    PubMed  CAS  Google Scholar 

  • Samuel CE (2001) Antiviral actions of interferons. Clin Microbiol Rev 14:778–809.

    Article  PubMed  CAS  Google Scholar 

  • Saverino D, Ghiotto F, Merlo A, Bruno S, Battini L, Occhino M, Maffei M, Tenca C, Pileri S, Baldi L, Fabbi M, Bachi A, De Santanna A, Grossi CE, Ciccone E (2004) Specific recognition of the viral protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T cells mediates the non-MHC-restricted lysis of human cytomegalovirus-infected cells. J Immunol 172:5629–5637.

    PubMed  CAS  Google Scholar 

  • Scalzo AA (2002) Successful control of viruses by NK cells–a balance of opposing forces? Trends Microbiol 10:470–474.

    Article  PubMed  CAS  Google Scholar 

  • Scalzo AA, Fitzgerald NA, Simmons A, La Vista AB, Shellam GR (1990) Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J Exp Med 171:1469–1483.

    Article  PubMed  CAS  Google Scholar 

  • Scalzo AA, Lyons PA, Fitzgerald NA, Forbes CA, Yokoyama WM, Shellam GR (1995) Genetic mapping of Cmv1 in the region of mouse chromosome 6 encoding the NK gene complex-associated loci Ly49 and musNKR-P1. Genomics 27:435–441.

    Article  PubMed  CAS  Google Scholar 

  • Schneider RJ, Mohr I (2003) Translation initiation and viral tricks. Trends Biochem Sci 28: 130–136.

    Article  PubMed  CAS  Google Scholar 

  • Schoenhals GJ, Krishna RM, Grandea AG 3rd, Spies T, Peterson PA, Yang Y, Fruh K (1999) Retention of empty MHC class I molecules by tapasin is essential to reconstitute antigen presentation in invertebrate cells. EMBO J 18:743–753.

    Article  PubMed  CAS  Google Scholar 

  • Shuai K, Liu B (2003) Regulation of JAK-STAT signalling in the immune system. Nat Rev Immunol 3:900–911.

    Article  PubMed  CAS  Google Scholar 

  • Simmen KA, Singh J, Luukkonen BG, Lopper M, Bittner A, Miller NE, Jackson MR, Compton T, Fruh K (2001) Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. Proc Natl Acad Sci U S A 98:7140–7145.

    Article  PubMed  CAS  Google Scholar 

  • Smith HR, Heusel JW, Mehta IK, Kim S, Dorner BG, Naidenko OV, Iizuka K, Furukawa H, Beckman DL, Pingel JT, Scalzo AA, Fremont DH, Yokoyama WM (2002) Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA 99:8826–8831.

    PubMed  CAS  Google Scholar 

  • Smith LM, Shellam GR, Redwood AJ (2006) Genes of murine cytomegalovirus exist as a number of distinct genotypes. Virology 352:450–465.

    Article  PubMed  CAS  Google Scholar 

  • Spreu J, Stehle T, Steinle A (2006) Human cytomegalovirus-encoded UL16 discriminates MIC molecules by their alpha2 domains. J Immunol 177:3143–3149.

    PubMed  CAS  Google Scholar 

  • Stern-Ginossar N, Elefant N, Zimmermann A, Wolf DG, Saleh N, Biton M, Horwitz E, Prokocimer Z, Prichard M, Hahn G, Goldman-Wohl D, Greenfield C, Yagel S, Hengel H, Altuvia Y, Margalit H, Mandelboim O (2007) Host immune system gene targeting by a viral miRNA. Science 317:376–381.

    Article  PubMed  CAS  Google Scholar 

  • Sutherland CL, Chalupny NJ, Schooley K, VandenBos T, Kubin M, Cosman D (2002) UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells. J Immunol 168:671–679.

    PubMed  CAS  Google Scholar 

  • Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, Ban T, Lu Y, Miyagishi M, Kodama T, Honda K, Ohba Y, Taniguchi T (2007) DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448:501–505.

    Article  PubMed  CAS  Google Scholar 

  • Takeuchi O, Akira S (2001) Toll-like receptors; their physiological role and signal transduction system. Int Immunopharmacol 1:625–635.

    Article  PubMed  CAS  Google Scholar 

  • Tanaka K, Numazaki K, Tsutsumi H (2005) Human cytomegalovirus genetic variability in strains isolated from Japanese children during 1983–2003. J Med Virol 76:356–360.

    Article  PubMed  CAS  Google Scholar 

  • Tay CH, Szomolanyi-Tsuda E, Welsh RM (1998) Control of infections by NK cells. Curr Top Microbiol Immunol 230:193–220.

    PubMed  CAS  Google Scholar 

  • Taylor RT, Bresnahan WA (2005) Human cytomegalovirus immediate-early 2 gene expression blocks virus-induced beta interferon production. J Virol 79:3873–3877.

    Article  PubMed  CAS  Google Scholar 

  • Taylor RT, Bresnahan WA (2006a) Human cytomegalovirus IE86 attenuates virus- and tumor necrosis factor alpha-induced NFkappaB-dependent gene expression. J Virol 80:10763–10771.

    Article  PubMed  CAS  Google Scholar 

  • Taylor RT, Bresnahan WA (2006b) Human cytomegalovirus immediate-early 2 protein IE86 blocks virus-induced chemokine expression. J Virol 80:920–928.

    Article  PubMed  CAS  Google Scholar 

  • Thammavongsa V, Raghuraman G, Filzen TM, Collins KL, Raghavan M (2006) HLA-B44 polymorphisms at position 116 of the heavy chain influence TAP complex binding via an effect on peptide occupancy. J Immunol 177:3150–3161.

    PubMed  CAS  Google Scholar 

  • Tirabassi RS, Ploegh HL (2002) The human cytomegalovirus US8 glycoprotein binds to major histocompatibility complex class I products. J Virol 76:6832–6835.

    Article  PubMed  CAS  Google Scholar 

  • Tomasec P, Braud VM, Rickards C, Powell MB, McSharry BP, Gadola S, Cerundolo V, Borysiewicz LK, McMichael AJ, Wilkinson GW (2000) Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287:1031.

    Article  PubMed  CAS  Google Scholar 

  • Tomasec P, Wang EC, Davison AJ, Vojtesek B, Armstrong M, Griffin C, McSharry BP, Morris RJ, Llewellyn-Lacey S, Rickards C, Nomoto A, Sinzger C, Wilkinson GW (2005) Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141. Nat Immunol 6:181–188.

    Article  PubMed  CAS  Google Scholar 

  • Torigoe S, Campbell DE, Torigoe F, Michelson S, Starr SE (1993) Cytofluorographic analysis of effects of interferons on expression of human cytomegalovirus proteins. J Virol Methods 45:219–228.

    Article  PubMed  CAS  Google Scholar 

  • Uetz P, Dong YA, Zeretzke C, Atzler C, Baiker A, Berger B, Rajagopala SV, Roupelieva M, Rose D, Fossum E, Haas J (2006) Herpesviral protein networks and their interaction with the human proteome. Science 311:239–242.

    Article  PubMed  CAS  Google Scholar 

  • Ulbrecht M, Martinozzi S, Grzeschik M, Hengel H, Ellwart JW, Pla M, Weiss EH (2000) Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis. J Immunol 164:5019–5022.

    PubMed  CAS  Google Scholar 

  • Vales-Gomez M, Reyburn HT (2006) Intracellular trafficking of the HCMV immunoevasin UL16 depends on elements present in both its cytoplasmic and transmembrane domains. J Mol Biol 363:908–917.

    Article  PubMed  CAS  Google Scholar 

  • Vales-Gomez M, Shiroishi M, Maenaka K, Reyburn HT (2005) Genetic variability of the major histocompatibility complex class I homologue encoded by human cytomegalovirus leads to differential binding to the inhibitory receptor ILT2. J Virol 79:2251–2260.

    Article  PubMed  CAS  Google Scholar 

  • van der Wal FJ, Kikkert M, Wiertz E (2002) The HCMV gene products US2 and US11 target MHC class I molecules for degradation in the cytosol. Curr Top Microbiol Immunol 269:37–55.

    PubMed  Google Scholar 

  • Vance RE, Kraft JR, Altman JD, Jensen PE, Raulet DH (1998) Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J Exp Med 188:1841–1848.

    Article  PubMed  CAS  Google Scholar 

  • Varnum SM, Streblow DN, Monroe ME, Smith P, Auberry KJ, Pasa-Tolic L, Wang D, Camp DG 2nd, Rodland K, Wiley S, Britt W, Shenk T, Smith RD, Nelson JA (2004) Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J Virol 78:10960–10966.

    Article  PubMed  CAS  Google Scholar 

  • Voigt S, Sandford GR, Ding L, Burns WH (2001) Identification and characterization of a spliced C-type lectin-like gene encoded by rat cytomegalovirus. J Virol 75:603–611.

    Article  PubMed  CAS  Google Scholar 

  • Voigt V, Forbes CA, Tonkin JN, Degli-Esposti MA, Smith HR, Yokoyama WM, Scalzo AA (2003) Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc Natl Acad Sci U S A 100:13483–13488.

    Article  PubMed  CAS  Google Scholar 

  • Voigt S, Mesci A, Ettinger J, Fine JH, Chen P, Chou W, Carlyle JR (2007) Cytomegalovirus evasion of innate immunity by subversion of the NKR-P1B:Clr-b missing-self axis. Immunity 26:617–627.

    Article  PubMed  CAS  Google Scholar 

  • Wagner CS, Riise GC, Bergstrom T, Karre K, Carbone E, Berg L (2007) Increased expression of leukocyte Ig-like receptor-1 and activating role of UL18 in the response to cytomegalovirus infection. J Immunol 178:3536–3543.

    PubMed  CAS  Google Scholar 

  • Wang EC, McSharry B, Retiere C, Tomasec P, Williams S, Borysiewicz LK, Braud VM, Wilkinson GW (2002) UL40-mediated NK evasion during productive infection with human cytomegalovirus. Proc Natl Acad Sci U S A 99:7570–7575.

    Article  PubMed  CAS  Google Scholar 

  • Ware CF (2003) The TNF superfamily. Cytokine Growth Factor Rev 14:181–184.

    Article  PubMed  CAS  Google Scholar 

  • Wathelet MG, Lin CH, Parekh BS, Ronco LV, Howley PM, Maniatis T (1998) Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol Cell 1:507–518.

    Article  PubMed  CAS  Google Scholar 

  • Welte SA, Sinzger C, Lutz SZ, Singh-Jasuja H, Sampaio KL, Eknigk U, Rammensee HG, Steinle A (2003) Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Eur J Immunol 33:194–203.

    Article  PubMed  CAS  Google Scholar 

  • Wiertz EJ, Devlin R, Collins HL, Ressing ME (2007) Herpesvirus interference with major histocompatibility complex class II-restricted T-cell activation. J Virol 81:4389–4396.

    Article  PubMed  CAS  Google Scholar 

  • Willcox BE, Thomas LM, Bjorkman PJ (2003) Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat Immunol 4:913–919.

    Article  PubMed  CAS  Google Scholar 

  • Williams AP, Peh CA, Purcell AW, McCluskey J, Elliott T (2002) Optimization of the MHC class I peptide cargo is dependent on tapasin. Immunity 16:509–520.

    Article  PubMed  CAS  Google Scholar 

  • Wills MR, Ashiru O, Reeves MB, Okecha G, Trowsdale J, Tomasec P, Wilkinson GW, Sinclair J, Sissons JG (2005) Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysis. J Immunol 175:7457–7465.

    PubMed  CAS  Google Scholar 

  • Wu J, Chalupny NJ, Manley TJ, Riddell SR, Cosman D, Spies T (2003) Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein. J Immunol 170:4196–4200.

    PubMed  CAS  Google Scholar 

  • Xie X, Dighe A, Clark P, Sabastian P, Buss S, Brown MG (2007) Deficient major histocompatibility complex-linked innate murine cytomegalovirus immunity in MA/My.L-H2b mice and viral downregulation of H-2k class I proteins. J Virol 81:229–236.

    Article  PubMed  CAS  Google Scholar 

  • Ye Y, Shibata Y, Yun C, Ron D, Rapoport TA (2004) A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 429:841–847.

    Article  PubMed  CAS  Google Scholar 

  • Yeow WS, Lawson CM, Beilharz MW (1998) Antiviral activities of individual murine IFN-alpha subtypes in vivo: intramuscular injection of IFN expression constructs reduces cytomegalovirus replication. J Immunol 160:2932–2939.

    PubMed  CAS  Google Scholar 

  • Yewdell JW, Hill AB (2002) Viral interference with antigen presentation. Nat Immunol 3:1019–1025.

    Article  PubMed  CAS  Google Scholar 

  • Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5:730–737.

    Article  PubMed  CAS  Google Scholar 

  • Yu D, Silva MC, Shenk T (2003) Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc Natl Acad Sci U S A 100:12396–12401.

    Article  PubMed  CAS  Google Scholar 

  • Ziegler H, Thale R, Lucin P, Muranyi W, Flohr T, Hengel H, Farrell H, Rawlinson W, Koszinowski UH (1997) A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 6:57–66.

    Article  PubMed  CAS  Google Scholar 

  • Zimmermann A, Trilling M, Wagner M, Wilborn M, Bubic I, Jonjic S, Koszinowski U, Hengel H (2005) A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses. J Exp Med 201:1543–1553.

    Article  PubMed  CAS  Google Scholar 

  • Zou Y, Bresnahan W, Taylor RT, Stastny P (2005) Effect of human cytomegalovirus on expression of MHC class I-related chains A. J Immunol 174:3098–3104.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Vaccine and Gene Therapy Institute, Oregon Health and Science University, 97201, Portland, OR, USA

    C. Powers, V. DeFilippis, D. Malouli & K. Früh

Authors
  1. C. Powers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. DeFilippis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Malouli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Früh
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Princeton University, 08544-1014, Princeton, NJ, USA

    Thomas E. Shenk

  2. University of Iowa, 52242, Iowa, IA, USA

    Mark F. Stinski

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Powers, C., DeFilippis, V., Malouli, D., Früh, K. (2008). Cytomegalovirus Immune Evasion. In: Shenk, T.E., Stinski, M.F. (eds) Human Cytomegalovirus. Current Topics in Microbiology and Immunology, vol 325. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-77349-8_19

Download citation

Publish with us

Policies and ethics

Search

Navigation